A panel of intestinal differentiation markers (CDX2, GPA33, and LI-cadherin) identifies gastric cancer patients with favourable prognosis.

Nair LopesChristian BergslandJarle BruunMerete BjørnslettAndré Filipe VieiraPatrícia MesquitaRita PintoRosa GomesBruno CavadasEric BennettLuisa PereiraRagnhild A LotheRaquel AlmeidaLeonor David

Published in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (2020)

Expression of the intestinal differentiation panel (CDX2, GPA33, and LI-cadherin) defines a set of biomarkers with a strong biological rationale and favourable impact for prognostication of gastric cancer patients.

Keyphrases

ion batteries
poor prognosis
cell migration
cell adhesion
genome wide
binding protein
dna methylation
gene expression
long non coding rna